Home/Pipeline/Malaria-on-a-Chip Model

Malaria-on-a-Chip Model

Malaria

Pre-clinicalActive

Key Facts

Indication
Malaria
Phase
Pre-clinical
Status
Active
Company

About Hesperos

Hesperos is a privately held, US-based biotech firm founded in 2015, specializing in advanced organ-on-a-chip systems. Its core technology involves interconnected, reconfigurable platforms that simulate the functional aspects of human organs, aiming to reduce animal testing and improve the predictability of drug development. The company operates a service-based business model, offering custom disease modeling and drug testing assays to research institutes and pharmaceutical partners. Hesperos is positioned as a leader in this niche field, leveraging strong academic foundations and intellectual property.

View full company profile

Other Malaria Drugs

DrugCompanyPhase
Vaxine Malaria VaccineVaxinePreclinical
Malaria VaccineVLP BiotechPre-clinical
Malaria Antibodiesnew/era/mabsResearch/Pre-clinical
Dendritic Cell VaccineMegaNano BioTechPre-clinical
MalariaKeltic Pharma TherapeuticsPre-clinical
Antibody Programs (Malaria)Ibex BiosciencesPre-clinical
Malaria RDTsAccess BioCommercial
Malaria NanobodyVicuTec BiologicalsPre-clinical